Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Classement en actions #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Prix de l'action
$0.00001
Dernière synchronisation: 2025-12-30
Capitalisation boursière
$6.89K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange AVAX Technologies, Inc. (AVXT)

Catégorie

Historique du prix de l'action pour AVAX Technologies, Inc. (AVXT)
Prix de clôture le plus élevé : $0.00 le 2025-12-01

Prix de clôture le plus bas : $5.70 le 1997-05-01
Historique du prix de l'action de AVAX Technologies, Inc. de 1997 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 0.00%
2024 -90.00%
2023 0.00%
2022 -29.03%
2021 -92.02%
2020 29.21%
2019 62.70%
2018 -57.93%
2017 -45.69%
2016 -85.27%
2015 184.66%
2014 150.18%
2013 -39.36%
2012 -82.52%
2011 -23.65%
2010 -61.01%
2009 671.71%
2008 -87.28%
2007 -15.34%
2006 -53.45%
2005 27.11%
2004 26.14%
2003 -8.09%
2002 -67.56%
2001 -85.17%
2000 -25.37%
1999 125.74%
1998 -36.11%
1997 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.46%
KR